The company’s net sales increased by 4.8 percent, from $1.03 billion in 2012 to $1.07 billion this year. However, increased operating costs offset the increased sales.
Spine device sales decreased slightly in this year’s third quarter, down 3.6 percent from last year. Major gains were made in knee devices, for which sales were up 5.6 percent.
More Articles on Devices:
Exactech Income Increases 25% in Q3
Mazor Robotics’ Renaissance Reaches 5k Procedures
15 New Spine, Orthopedic Device Launches & Releases
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
